0.00
                                            Schlusskurs vom Vortag:
              $7.04
            Offen:
              $0
            24-Stunden-Volumen:
                0
            Relative Volume:
              0.00
            Marktkapitalisierung:
                $1.08B
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-3.12M
            KGV:
              0.00
            EPS:
                -4.8149
            Netto-Cashflow:
                $-2.69M
            1W Leistung:
              -100.00%
            1M Leistung:
              -100.00%
            6M Leistung:
                -100.00%
            1J Leistung:
              -100.00%
            180 Life Sciences Corp Stock (ATNF) Company Profile
Firmenname
                  
                      180 Life Sciences Corp
                    
                Sektor
                  Branche
                  Telefon
                  
                      650-507-0669
                    
                Adresse
                  
                      3000 EL CAMINO REAL, PALO ALTO
                    
                Vergleichen Sie ATNF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ATNF
                            
                             
                        180 Life Sciences Corp 
                           | 
                    0.00 | 1.08B | 0 | -3.12M | -2.69M | -4.8149 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2021-09-15 | Eingeleitet | Maxim Group | Buy | 
180 Life Sciences Corp Aktie (ATNF) Neueste Nachrichten
Can volume confirm reversal in 180 Life Sciences Corp. Equity WarrantMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Will 180 Life Sciences Corp. stock continue upward momentumJuly 2025 PreEarnings & Free Fast Entry Momentum Trade Alerts - newser.com
What dividend safety score for 180 Life Sciences Corp. stockInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
Custom watchlist performance reports with 180 Life Sciences Corp.Earnings Risk Summary & Smart Swing Trading Alerts - newser.com
Is this a good reentry point in 180 Life Sciences Corp.Earnings Growth Summary & Verified Momentum Watchlists - newser.com
Can 180 Life Sciences Corp. hit a new high this month2025 Top Decliners & Smart Swing Trading Techniques - newser.com
How sentiment analysis helps forecast 180 Life Sciences Corp. - newser.com
Why 180 Life Sciences Corp. Equity Warrant stock could outperform in 20252025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Published on: 2025-11-03 08:35:53 - newser.com
How 180 Life Sciences Corp. Equity Warrant stock reacts to Fed rate cutsEntry Point & AI Forecasted Entry/Exit Points - newser.com
How resilient is 180 Life Sciences Corp. stock in market downturnsTake Profit & Consistent Growth Equity Picks - newser.com
Trend analysis for 180 Life Sciences Corp. Equity Warrant this weekPortfolio Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Is 180 Life Sciences Corp. stock overvalued by current metricsJuly 2025 Selloffs & Low Drawdown Investment Strategies - newser.com
180 Life Sciences Corp. Equity Warrant stock prediction for this weekJuly 2025 Gainers & Weekly Return Optimization Alerts - newser.com
Real time scanner hits for 180 Life Sciences Corp. explainedPortfolio Return Report & Free Expert Approved Momentum Trade Ideas - newser.com
What candlestick patterns are forming on 180 Life Sciences Corp. Equity WarrantMarket Growth Review & High Conviction Investment Ideas - newser.com
How strong is 180 Life Sciences Corp. Equity Warrant stock revenue growth2025 Winners & Losers & Verified Technical Signals - newser.com
Custom strategy builders for tracking 180 Life Sciences Corp. Equity Warrant2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Visual trend scoring systems applied to 180 Life Sciences Corp.July 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com
How to manage a losing position in 180 Life Sciences Corp.2025 Trading Volume Trends & Daily Profit Maximizing Tips - newser.com
Strategies to average down on 180 Life Sciences Corp.New Guidance & Safe Entry Momentum Tips - newser.com
Can you recover from losses in 180 Life Sciences Corp.2025 Stock Rankings & Long-Term Safe Investment Plans - newser.com
How 180 Life Sciences Corp. stock performs in rate cut cyclesOil Prices & High Yield Stock Recommendations - newser.com
Will 180 Life Sciences Corp. stock remain a Wall Street favoriteMarket Sentiment Report & Daily Growth Stock Tips - newser.com
Reversal indicators forming on 180 Life Sciences Corp. stockWeekly Gains Report & Risk Controlled Swing Alerts - newser.com
Will 180 Life Sciences Corp. stock go up soonTrade Analysis Report & Fast Gain Stock Trading Tips - newser.com
Published on: 2025-11-03 01:10:07 - newser.com
How 180 Life Sciences Corp. Equity Warrant stock performs in high volatility marketsQuarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com
Short interest data insights for 180 Life Sciences Corp.Weekly Investment Report & Verified Entry Point Signals - newser.com
Institutional scanner results for 180 Life Sciences Corp. Equity Warrant2025 Performance Recap & Reliable Intraday Trade Plans - newser.com
What drives 180 Life Sciences Corp stock priceTechnology Stock Trends & Superior Capital Investment - earlytimes.in
Can 180 Life Sciences Corp. Equity Warrant stock deliver sustainable ROEEarnings Risk Summary & Weekly Watchlist for Consistent Profits - newser.com
Will 180 Life Sciences Corp. continue its uptrend2025 Market Overview & Trade Opportunity Analysis Reports - newser.com
What valuation multiples suggest for 180 Life Sciences Corp. Equity Warrant stockTrade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Is 180 Life Sciences Corp. forming a reversal patternMarket Performance Summary & Accurate Intraday Trading Signals - newser.com
Understanding 180 Life Sciences Corp.’s price movementJuly 2025 PostEarnings & Pattern Based Trade Signal System - newser.com
Why 180 Life Sciences Corp. stock is recommended by analystsQuarterly Profit Review & AI Powered Market Trend Analysis - newser.com
Finanzdaten der 180 Life Sciences Corp-Aktie (ATNF)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):